...
首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Development of Micro-Emulsion Gel Based Topical Delivery of Salicylic Acid and Neem Oil for the Management of Psoriasis
【24h】

Development of Micro-Emulsion Gel Based Topical Delivery of Salicylic Acid and Neem Oil for the Management of Psoriasis

机译:基于微乳液的微乳液凝胶的局部递送水杨酸和NeeM油,用于牛皮癣管理

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Microemulsions (MEs) are clear, thermodynamically stable systems. They were used to solubilise drugs and to improve topical drug availability. Salicylic acid (SA) is a keratolytic agent used in topical products with antimicrobial actions. This study aimed to formulate an optimized SA micro emulsion gel for the slow, variable and incomplete oral drug absorption in patient suffering from psoriasis infection. The dispersion solubility of SA was studied in various oils, surfactants and co-surfactants and by constructing pseudo phase ternary diagram, micro emulsion area was identified. The optimized formulations of micro emulsion were subjected to thermodynamic stability tests. After stability study, stable formulation was characterized for droplet size, pH determination, centrifugation, % drug content in micro emulsion, zeta Potential and vesicle size measurement and then micro emulsion gel were prepared and characterized for spreadability, measurement of viscosity, drug content, In-vitro diffusion, in-vitro release data. Labrasol was selected as surfactant, plurol oleique as co surfactant and neem oil as oil component based on solubility study. The optimized formulation contained SA 0.05 (%w/w), labrasol (24%), plurol oleique (8 %) and neem oil (8%). The in vitro drug release from SA micro emulsion gel was found to be considerably higher in comparison to that of the pure drug. The in-vitro diffusion of micro emulsion gel was significantly good. Based on this study, it can be concluded the solubility and permeability of SA can be increased by formulating into micro emulsion gel.
机译:微乳液(MES)是透明的,热力学稳定的系统。它们被用来溶解药物并改善局部药物可用性。水杨酸(SA)是一种在具有抗微生物作用的局部产品中使用的角裂解剂。该研究旨在为患有牛皮癣感染的患者进行慢,可变和不完全口服药物吸收的优化SA微乳液凝胶。在各种油,表面活性剂和共表面活性剂中研究了SA的分散溶解度,并通过构建伪阶段三元图,鉴定了微乳液区域。对微乳液的优化制剂进行热力学稳定性试验。在稳定性研究之后,稳定的制剂的特征在于液滴尺寸,pH测定,离心,Micro乳液中的%药物含量,Zeta电位和囊泡尺寸测量,然后制备微乳液凝胶,并表征渗透性,测量粘度,药物含量,药物含量, -vitro扩散,体外释放数据。基于溶解性研究选择粘土醇作为CO表面活性剂和Neem油作为Co表面活性剂和Neem油。优化的制剂含有0.05(%w / w),唇淋醇(24%),Plurol oleique(8%)和雷姆油(8%)。与纯药物相比,发现来自SA微乳液凝胶的体外药物释放相当高。微乳液凝胶的体外扩散显着良好。基于该研究,可以得出结论,通过将微乳液凝胶制成,可以增加SA的溶解度和渗透性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号